87,355 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Bought by Raymond James Financial Inc.

Raymond James Financial Inc. purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 87,355 shares of the company's stock, valued at approximately $2,027,000. Raymond James Financial Inc. owned approximately 0.05% of Option Care Health as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. UMB Bank n.a. raised its position in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after acquiring an additional 346 shares in the last quarter. Quarry LP raised its holdings in Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company's stock worth $107,000 after purchasing an additional 2,628 shares in the last quarter. Blue Trust Inc. lifted its position in Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after buying an additional 681 shares during the period. Venturi Wealth Management LLC boosted its holdings in shares of Option Care Health by 2,621.3% during the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock valued at $110,000 after buying an additional 4,561 shares in the last quarter. Finally, KBC Group NV grew its position in shares of Option Care Health by 46.4% in the 4th quarter. KBC Group NV now owns 7,337 shares of the company's stock worth $170,000 after buying an additional 2,324 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.64% of the stock is owned by insiders.

Option Care Health Stock Up 0.4 %

Shares of OPCH stock traded up $0.15 during mid-day trading on Thursday, hitting $34.94. The company's stock had a trading volume of 1,740,927 shares, compared to its average volume of 1,721,542. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The stock has a market cap of $5.74 billion, a price-to-earnings ratio of 29.36, a PEG ratio of 2.30 and a beta of 1.33. The business has a 50-day moving average price of $32.90 and a 200 day moving average price of $28.51.

Analyst Ratings Changes

OPCH has been the subject of a number of recent research reports. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and lifted their price target for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JMP Securities reiterated a "market outperform" rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. JPMorgan Chase & Co. lifted their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. Finally, UBS Group initiated coverage on Option Care Health in a research note on Thursday, December 5th. They issued a "neutral" rating and a $26.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.